Shree Pushkar Chemicals & Fertilisers Limited (SHREEPUSHK)
Please find attached herewith
AI summary
- Q1 FY27 revenue grew 10.0% YoY to Rs. 280.1 Cr; EBITDA Rs. 31.9 Cr (+9.7% YoY, margin 11.4%); PAT Rs. 22.9 Cr (+9.4% YoY, margin 8.2%)
- Fertiliser sales volume declined to 66,527 MT from 76,288 MT in Q1 FY26; sales value grew 4.0% YoY to Rs. 142 Cr
- Chemical sales volume declined to 9,113 MT from 14,837 MT; sales value grew 17.1% YoY to Rs. 138 Cr
- Expansion projects at Ratnagiri Units 5 and 6 nearing completion; timing of commencement under evaluation due to raw material volatility
- Acquired 30,000 sq. metres land at Lote Parshuram for Rs. 9.33 Cr to support future expansion
- FY26 revenue Rs. 976.6 Cr (+21% YoY); EBITDA Rs. 99.5 Cr (+19% YoY, margin 10.2%); PAT Rs. 70.1 Cr (+20% YoY)
- Strategic expansions include 4,50,000 MTPA additional fertiliser capacity, 72,000 MTPA chemical capacity, and 10 MW DC solar capacity funded by internal accruals and preferential issue
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 SHREEPUSHK — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add SHREEPUSHK to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Shree Pushkar Chemicals & Fertilisers Limited
Important.
The summary above is generated automatically from Shree Pushkar Chemicals & Fertilisers Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.